Neuberger Berman Group
NVAX icon

Neuberger Berman Group’s Novavax NVAX Stock Holding History

Neuberger Berman Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,559
Closed -$697K – 1881
2022
Q2 		$697K Buy
13,559
+10,795
+391% +$559K ﹤0.01% 1397
2022
Q1 		$204K Buy
2,764
+715
+35% +$63.8K ﹤0.01% 1807
2021
Q4 		$238K Buy
+2,049
New +$352K ﹤0.01% 1789
2021
Q2 		– Sell
-5,585
Closed -$971K – 1812
2021
Q1 		$971K Sell
5,585
-2,952
-35% -$588K ﹤0.01% 1335
2020
Q4 		$948K Buy
8,537
+37
+0.4% +$3.93K ﹤0.01% 1272
2020
Q3 		$921K Buy
+8,500
New +$1.04M ﹤0.01% 1239
2015
Q1 		– Sell
-10,060
Closed -$1.19M – 1639
2014
Q4 		$1.19M Buy
10,060
+1,170
+13% +$122K ﹤0.01% 1185
2014
Q3 		$741K Sell
8,890
-695
-7% -$62.8K ﹤0.01% 1301
2014
Q2 		$886K Sell
9,585
-745
-7% -$65.5K ﹤0.01% 1275
2014
Q1 		$936K Buy
+10,330
New +$1.15M ﹤0.01% 1231

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Neuberger Berman Group's NVAX Position: Q3 2022 in Review

Neuberger Berman Group sold out of Novavax (NVAX) in Q3 2022, closing a stake of 13,559 shares — an estimated $697K sold.

Neuberger Berman Group first reported a position in NVAX in Q1 2014 and held it in 10 quarters. The position peaked at $1.19M in Q4 2014. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Neuberger Berman Group reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 13,559 Novavax shares in Q3 2022, an estimated $697K.
  • Neuberger Berman Group first reported a position in Novavax in Q1 2014 and held it in 10 quarters.
  • Neuberger Berman Group's Novavax position peaked at $1.19M in Q4 2014.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Neuberger Berman Group's 13F filing for Q3 2022, filed 15 Nov 2022.